UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

Transfusion (Philadelphia, Pa.), 2002-08, Vol.42 (8), p.975-979

2002

Volltextzugriff (PDF)

PL4‐AM23‐SN‐30 | Syphilis Seroprevalence and Incidence in Blood Donors from 2020 to 2022, on Behalf of the US TTIMS Program

Transfusion (Philadelphia, Pa.), 2023-10, Vol.63 (S5), p.12A-13A

2023

Volltextzugriff (PDF)

Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States

The New England journal of medicine, 1995-12, Vol.333 (26), p.1721-1725

1995

Volltextzugriff (PDF)

Current impact of the confidential unit exclusion option

Transfusion (Philadelphia, Pa.), 2004-05, Vol.44 (5), p.651-657

2004

Volltextzugriff (PDF)

Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross

Transfusion (Philadelphia, Pa.), 2007-05, Vol.47 (5), p.890-894

2007

Volltextzugriff (PDF)

Transfusion-transmissible coinfections among US blood donors

Transfusion (Philadelphia, Pa.), 2024-10

2024

Volltextzugriff (PDF)

Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions

Journal of pharmaceutical sciences, 1998-12, Vol.87 (12), p.1572-1576

1998

Volltextzugriff (PDF)

Influence of pH, Temperature, and Buffers on the Kinetics of Ceftazidime Degradation in Aqueous Solutions

Journal of pharmaceutical sciences, 1995-05, Vol.84 (5), p.534-538

1995

Volltextzugriff (PDF)

Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L

Transfusion (Philadelphia, Pa.), 2001-06, Vol.41 (6), p.751-755

2001

Volltextzugriff (PDF)

HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015–2020

Open forum infectious diseases, 2024-07, Vol.11 (7), p.ofae343

2024

Volltextzugriff (PDF)

A Kinetic Oxymoron: Concentration-Dependent First-Order Rate Constants for Hydrolysis of Ceftazidime

Journal of pharmaceutical sciences, 1998-01, Vol.87 (1), p.53-58

1998

Volltextzugriff (PDF)

Cefuroxime Hydrolysis Kinetics and Stability Predictions in Aqueous Solution

Journal of pharmaceutical sciences, 1994-04, Vol.83 (4), p.577-581

1994

Volltextzugriff (PDF)

Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening

Transfusion (Philadelphia, Pa.), 1999-02, Vol.39 (2), p.206-211

1999

Volltextzugriff (PDF)

A Nomogram To Predict the Best Biological Half-Life Values for Candidates for Oral Prolonged-Release Formulations

Journal of pharmaceutical sciences, 1996-08, Vol.85 (8), p.791-795

1996

Volltextzugriff (PDF)

Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers

International journal of pharmaceutics, 1998-10, Vol.173 (1), p.221-232

1998

Volltextzugriff (PDF)

Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT)

Developments in biologicals, 2000, Vol.102, p.19

2000

Volltextzugriff (PDF)

A Nomogram to Evaluate Intrinsic Absorption Rate Constants of Potential Oral Prolonged-Release Candidates

Pharmaceutical development and technology, 1999, Vol.4 (3), p.305-312

1999

Volltextzugriff (PDF)

Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study

Transfusion (Philadelphia, Pa.), 2004-11, Vol.44 (11), p.1640-1647

2004

Volltextzugriff (PDF)

Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study

Transfusion (Philadelphia, Pa.), 2005-10, Vol.45 (10), p.1593-1600

2005

Volltextzugriff (PDF)

Methodology for using oral dose pharmacokinetic data to select drugs for prolonged release formulations and validation of the method using simulated data

Biopharmaceutics & drug disposition, 1995-05, Vol.16 (4), p.319-331

1995

Volltextzugriff (PDF)

Computer-aided dosage form design. III, Feasibility assessment for an oral prolonged-release phenytoin product

Pharmaceutical research, 1991-02, Vol.8 (2), p.232-237

1991

Volltextzugriff (PDF)

Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure

Pharmaceutical research, 1987-04, Vol.4 (2), p.98-103

1987

Volltextzugriff (PDF)

An efficient method for computer-aided dosage form design

Computers in biology and medicine, 1993-11, Vol.23 (6), p.475-482

1993

Volltextzugriff (PDF)

Prodrug design

Pharmacology & therapeutics (Oxford), 1981, Vol.14 (1), p.25-53

Notari, Robert E.

1981

Volltextzugriff (PDF)

Potential improvement in the shelf life of parenterals using the prodrug approach: bacampicillin and talampicillin hydrolysis kinetics and utilization time

Pharmaceutical research, 1988-05, Vol.5 (5), p.288-296

1988

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(242)
Mit Volltextzugriff
(230)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population

PL4‐AM23‐SN‐30 | Syphilis Seroprevalence and Incidence in Blood Donors from 2020 to 2022, on Behalf of the US TTIMS Program

Estimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States

Current impact of the confidential unit exclusion option

Seasonal temperature variation and the rate of donor deferral for low hematocrit in the American Red Cross

Transfusion-transmissible coinfections among US blood donors

Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions

Influence of pH, Temperature, and Buffers on the Kinetics of Ceftazidime Degradation in Aqueous Solutions

Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per L

HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015–2020

A Kinetic Oxymoron: Concentration-Dependent First-Order Rate Constants for Hydrolysis of Ceftazidime

Cefuroxime Hydrolysis Kinetics and Stability Predictions in Aqueous Solution

Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening

A Nomogram To Predict the Best Biological Half-Life Values for Candidates for Oral Prolonged-Release Formulations

Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers

Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT)

A Nomogram to Evaluate Intrinsic Absorption Rate Constants of Potential Oral Prolonged-Release Candidates

Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study

Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study

Methodology for using oral dose pharmacokinetic data to select drugs for prolonged release formulations and validation of the method using simulated data

Computer-aided dosage form design. III, Feasibility assessment for an oral prolonged-release phenytoin product

Kinetics and mechanism of captopril oxidation in aqueous solution under controlled oxygen partial pressure

An efficient method for computer-aided dosage form design

Prodrug design

Potential improvement in the shelf life of parenterals using the prodrug approach: bacampicillin and talampicillin hydrolysis kinetics and utilization time

Suchergebnisse filtern